ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 107,23
0,19%
Dow Jones
39 671,04
-0,51%
DAX
18 730,55
0,26%
Brent Oil
82,315
0,96%
Bitcoin
69 696,76
0,86%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Achieve Life Sciences Inc (ACHV)

  7. Achieve Life Sciences Inc (ACHV) Actualités

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACHV
DateHeureSourceTitreSymboleSociété
20/05/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACHVAchieve Life Sciences Inc
17/05/202420h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACHVAchieve Life Sciences Inc
17/05/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
09/05/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
09/05/202422h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
07/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
06/05/202417h16GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineNASDAQ:ACHVAchieve Life Sciences Inc
25/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024NASDAQ:ACHVAchieve Life Sciences Inc
11/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceNASDAQ:ACHVAchieve Life Sciences Inc
28/03/202421h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
20/03/202413h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/03/202413h00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024NASDAQ:ACHVAchieve Life Sciences Inc
06/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h01GlobeNewswire Inc.Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA SubmissionNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
26/10/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023NASDAQ:ACHVAchieve Life Sciences Inc
03/10/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
11/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
01/08/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and WebcastNASDAQ:ACHVAchieve Life Sciences Inc
18/07/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
11/07/202317h23GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)NASDAQ:ACHVAchieve Life Sciences Inc
26/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHVAchieve Life Sciences Inc
25/05/202322h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACHVAchieve Life Sciences Inc
25/05/202315h00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct OfferingNASDAQ:ACHVAchieve Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ACHV

Dernières Valeurs Consultées

LSE
JSG
Johnson Service
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés